This measure identifies adult patients with rheumatoid arthritis who were prescribed at least a 6-month supply of methotrexate during the measurement year and received a liver function test (LFT) in the 120 days (3 months + 1 month grace period) following the earliest observed methotrexate prescription claim.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Patients in the denominator who received a liver function test within 120 days following the earliest observed methotrexate prescription claim.
Time Window: See below
-
1.15 Denominator
Patients >=18 years old with rheumatoid arthritis who have received at least a 6-month supply of oral methotrexate during the measurement year.
Time Window: See below
-
Exclusions
Exclude members with an inpatient hospitalization during the 120 days after the earliest observed methotrexate prescription.
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Musculoskeletal Endorsement Maintenance ProjectInitial EndorsementLast UpdatedRemoval Date
-
StewardResolution Health, Inc.Steward Organization POC Email
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-